Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-26-000038

President and CEO acquired 143,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +143,200 347,296 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +415,700 415,700 D
Loading xslF345X05/wk-form4_1767734357.xml…